The Board resolution No.38 dated August 11, 2020, the BOD of Imexpharm Corporation (IMP) approved the following issues:
1) Approving the business result in first six months of 2020:
- Total revenue & other: 597.3 billion dongs
- Net revenue: 592.4 billion dongs
- Profit before tax: 110.7 billion dongs
- Profit after tax: 88.4 billion dongs.
2) Approving the business plan in last six months of 2020:
No.
Content
2020 (F)
% plan in 2020
2019
% Growth
1
Total revenue & other
1,575.0
90.0%
1,420.7
10.9%
2
Profit before tax and to distribute Science & Technology Development Fund
260.0
222.4
16.9%
3
Profit before tax
100%
202.4
28.5%
3) Approving the establishment of Functional Food Factory and Resting Center at No.04 Street 30/4, ward 1, Cao Lanh City, Dong Thap Province.